| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090375 Stratified and cryogenically stored vaccines, process for their preparation |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | US20020090362 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/11/2002 | US20020090352 Compositions and methods for use in modulating immune system function |
| 07/11/2002 | CA2708949A1 Immunizing compositions and methods of use |
| 07/11/2002 | CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | CA2434118A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2433967A1 Anti-inflammatory use of polycationic compounds |
| 07/11/2002 | CA2433573A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433263A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | CA2433236A1 Assay to determine efficacy of treatment for m. tuberculosis infection |
| 07/11/2002 | CA2433174A1 Cholesterol biosynthesis inhibitor containing tricyclic compound having spiro union as effective component |
| 07/11/2002 | CA2433125A1 Medicament containing a polyamine as an active substance |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2432076A1 Novel antibacterial carbapenem compounds |
| 07/10/2002 | EP1221446A1 Antibacterial cephalosporins |
| 07/10/2002 | EP1221316A1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 07/10/2002 | EP1221315A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220903A1 Gene selection using pnas |
| 07/10/2002 | EP1220902A2 Conjugates between a peptide and a nucleic acid analog, such as a pna, lna or a morpholino |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220868A1 Extracorporeal endotoxin removal method |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220858A2 Oxazinoquinolones useful for the treatment of viral infections |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220848A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220842A1 Cyclic amine compounds as ccr5 antagonists |
| 07/10/2002 | EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 07/10/2002 | EP1220686A2 Vaccine against neisseria infection |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220683A2 Mycophenolate mofetil in association with peg-ifn-alpha |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220677A1 Iodine containing antimicrobial compositions for mastitis control |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP1128723B1 Aromatic copolyester containing active ingredients |
| 07/10/2002 | EP1115420B1 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine |
| 07/10/2002 | EP0949929B1 Use of plant extract for inhibition of haemophilus influenzae |
| 07/10/2002 | EP0812206B1 Cd40 binding protein for stimulating an immune response |
| 07/10/2002 | EP0690862B1 Quinolone derivatives and processes for preparing the same |
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1358227A Production of the lipidated form of the peptido glycon-associated lipoproteins of gram-negative bacteria |
| 07/10/2002 | CN1358195A Inhibitors of integrin alpha V beta 6 |
| 07/10/2002 | CN1358194A Streptogramin derivatives, preparation and compositions containing them |
| 07/10/2002 | CN1358188A Diphosphate salt of A4'-substituted-9-deoxo-9A-aza 9A-homoerythromycin derivative and its pharmaceutical composition |
| 07/10/2002 | CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof |
| 07/10/2002 | CN1358183A Quinolinecarboxylic acid derivative or salts thereof |
| 07/10/2002 | CN1358182A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358181A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358180A Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358101A Method of controlling the qualities of attenuated pox vaccine |
| 07/10/2002 | CN1358097A Anionic polymers as toxin binders and antibacterial agents |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1358063A Effervescent green tea extract formulation |
| 07/10/2002 | CN1357548A Process for production of levo-ofloxacin |
| 07/10/2002 | CN1357547A Prepn. of levo-ofloxacin |
| 07/10/2002 | CN1357541A Phosphatidase A2 inhibitor and its prepn process and use |
| 07/10/2002 | CN1357373A Oral capsule for treating condyloma acuminata |
| 07/10/2002 | CN1357363A Malian granule for clearing away liver fire |
| 07/10/2002 | CN1357349A Virus eliminating medicine |
| 07/10/2002 | CN1357348A Zoster treating liniment |
| 07/10/2002 | CN1357332A Application of double-stranded ribonucleic acid in prepairng medicine for treaitng hepatic tumor and hepatitis B |
| 07/10/2002 | CN1357331A Suppository for controlling sexual spread of AIDS |
| 07/10/2002 | CN1357320A Taurine chewing gum and its making process |
| 07/10/2002 | CN1357243A Health milk and milk product containing rich ganglioside and their application |
| 07/10/2002 | CN1357230A Antibacterial composition diffused to resist bacteria in the air and its diffision method |
| 07/10/2002 | CN1087176C Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 07/10/2002 | CN1087175C Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
| 07/09/2002 | US6417352 Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid |
| 07/09/2002 | US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof |
| 07/09/2002 | US6417217 Prolines as antimicrobial agents |
| 07/09/2002 | US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417181 Viricides formed by catalytic hydrogenation |
| 07/09/2002 | US6417180 Zinc finger-reactive antimicrobial compounds |
| 07/09/2002 | US6417176 Arylsulfonanilide phosphates |
| 07/09/2002 | US6417175 Phosphonocephem derivatives, process for the preparation of the same, and use thereof |
| 07/09/2002 | US6417174 Inhibitors of β-lactamases and uses therefor |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417172 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416968 Methods of inhibiting Helicobacter pylori |
| 07/09/2002 | US6416779 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 07/09/2002 | US6416763 Recombinant nonstructural protein subunit vaccine against flaviviral infection |
| 07/09/2002 | US6415797 Treatment of human herpesviruses using hyperthermia |